New Jersey 2024-2025 Regular Session

New Jersey Assembly Bill A4015 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	ASSEMBLY, No. 4015 STATE OF NEW JERSEY 221st LEGISLATURE INTRODUCED MARCH 7, 2024
2	2
3	3	ASSEMBLY, No. 4015
4	4
5	5	STATE OF NEW JERSEY
6	6
7	7	221st LEGISLATURE
8	8
9	9
10	10
11	11	INTRODUCED MARCH 7, 2024
12	12
13	13
14	14
15	15	Sponsored by: Assemblywoman TENNILLE R. MCCOY District 14 (Mercer and Middlesex) SYNOPSIS Requires pharmacies to provide certain information regarding insulin manufacturer assistance programs. CURRENT VERSION OF TEXT As introduced.
16	16
17	17
18	18
19	19	Sponsored by:
20	20
21	21	Assemblywoman TENNILLE R. MCCOY
22	22
23	23	District 14 (Mercer and Middlesex)
24	24
25	25
26	26
27	27
28	28
29	29
30	30
31	31
32	32
33	33	SYNOPSIS
34	34
35	35	Requires pharmacies to provide certain information regarding insulin manufacturer assistance programs.
36	36
37	37
38	38
39	39	CURRENT VERSION OF TEXT
40	40
41	41	As introduced.
42	42
43	43
44	44
45	45	An Act concerning insulin manufacturer assistance programs and supplementing P.L.2003, c.280 (C.45:14-40 et seq.). Be It Enacted by the Senate and General Assembly of the State of New Jersey: 1. a. A pharmacy practice site shall: (1) display a notice concerning insulin manufacturer assistance programs, to be created by the Department of Banking and Insurance, at all points of sale; and (2) provide a pamphlet concerning insulin manufacturer assistance programs, to be created by the department, to an individual purchasing a prescription for insulin and any individual requesting a pamphlet. b. An insulin manufacturer offering an assistance program may inform the department of its intention to be included in the notices and pamphlets. c. The department shall adopt rules and regulations pursuant to the "Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.), to effectuate the purposes of this act. 2. This act shall take effect on the first day of the sixth month next following the date of enactment, except that the Commissioner of Banking and Insurance may take any anticipatory administrative action in advance as shall be necessary for the implementation of this act. STATEMENT This bill requires pharmacies to provide certain information regarding insulin manufacturer assistance programs. Under this bill, a pharmacy practice site will be required to display a notice, created by the Department of Banking and Insurance, concerning insulin manufacturer assistance programs at all points of sale. A pharmacy practice site will also be required to provide a pamphlet, created by the department, concerning the insulin manufacturer assistance programs to any individual purchasing a prescription for insulin, or to any individual requesting a pamphlet. Insulin manufacturers offering an assistance program may inform the department of their intention to be included in the notices and pamphlets.
46	46
47	47	An Act concerning insulin manufacturer assistance programs and supplementing P.L.2003, c.280 (C.45:14-40 et seq.).
48	48
49	49
50	50
51	51	Be It Enacted by the Senate and General Assembly of the State of New Jersey:
52	52
53	53
54	54
55	55	1. a. A pharmacy practice site shall:
56	56
57	57	(1) display a notice concerning insulin manufacturer assistance programs, to be created by the Department of Banking and Insurance, at all points of sale; and
58	58
59	59	(2) provide a pamphlet concerning insulin manufacturer assistance programs, to be created by the department, to an individual purchasing a prescription for insulin and any individual requesting a pamphlet.
60	60
61	61	b. An insulin manufacturer offering an assistance program may inform the department of its intention to be included in the notices and pamphlets.
62	62
63	63	c. The department shall adopt rules and regulations pursuant to the "Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.), to effectuate the purposes of this act.
64	64
65	65
66	66
67	67	2. This act shall take effect on the first day of the sixth month next following the date of enactment, except that the Commissioner of Banking and Insurance may take any anticipatory administrative action in advance as shall be necessary for the implementation of this act.
68	68
69	69
70	70
71	71
72	72
73	73	STATEMENT
74	74
75	75
76	76
77	77	This bill requires pharmacies to provide certain information regarding insulin manufacturer assistance programs.
78	78
79	79	Under this bill, a pharmacy practice site will be required to display a notice, created by the Department of Banking and Insurance, concerning insulin manufacturer assistance programs at all points of sale. A pharmacy practice site will also be required to provide a pamphlet, created by the department, concerning the insulin manufacturer assistance programs to any individual purchasing a prescription for insulin, or to any individual requesting a pamphlet. Insulin manufacturers offering an assistance program may inform the department of their intention to be included in the notices and pamphlets.